The ongoing evolution of SARS-CoV-2, particularly the rapid emergence of the omicron variant and its sublineages, has ...

Drug-drug interactions (DDIs) remain a critical challenge in both clinical practice and the drug discovery process, given their potential to produce unforeseen adverse effects and compromise patient ...

Protein-protein interactions (PPIs) are fundamental to operating cellular processes, as they regulate and coordinate various biological activities within the cell. These interactions govern a wide ...

What if the vast amounts of data generated by molecular dynamics simulations could be routinely shared and reused? A new €10 ...

Why do so many promising drugs fail? This article explores how spatial multiomics reveals hidden cell interactions, helping ...

Large language models (LLMs) can be broadly applied across multiple key stages in drug development: (1) Target identification and drug screening. Llama-Gram, GPCR LLM, and ProtChat systems effectively ...

Smart multi-target drugs are reshaping modern therapeutics by addressing the complex, interconnected pathways that drive diseases like Alzheimer’s, cancer, and major depressive disorder. Advances in ...

Researchers have identified six key proteins that could be targeted to combat MS progression, and potential drugs that could ...

• Hydrochlorothiazide, a generic drug for treating high blood pressure and fluid retention, can interact with various medications such as antidepressants, cholesterol-lowering drugs, and diabetes ...